# AMGEN INC (AMGN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from AMGEN INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AMGN/mda/fy2025/): filed 2026-02-13; accession 0000318154-26-000010 (https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/amgn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/AMGN/mda/fy2024/): filed 2025-02-14; accession 0000318154-25-000010 (https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/amgn-20241231.htm)
- [FY 2023 MD&A](/company/AMGN/mda/fy2023/): filed 2024-02-14; accession 0000318154-24-000011 (https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm)
- [FY 2022 MD&A](/company/AMGN/mda/fy2022/): filed 2023-02-09; accession 0000318154-23-000017 (https://www.sec.gov/Archives/edgar/data/318154/000031815423000017/amgn-20221231.htm)
- [FY 2021 MD&A](/company/AMGN/mda/fy2021/): filed 2022-02-16; accession 0000318154-22-000010 (https://www.sec.gov/Archives/edgar/data/318154/000031815422000010/amgn-20211231.htm)

Back to /company/AMGN/